Tag

NYSEARCA: XBI

Genmab A/S reports 45.9% Rina‑S response in ovarian cancer trial
Adrian Kessler · Oct 3, 2026
Nanexa AB shares jump 105% on Novo Nordisk drug-delivery licence
Adrian Kessler · Sep 25, 2026
aTyr Pharma says FDA aligned on 372‑patient sarcoidosis trial
Adrian Kessler · Sep 24, 2026
Mesoblast gets FDA approval for new Ryoncil potency assay
Adrian Kessler · Sep 24, 2026
Amgen says dazodalibep met Phase 3 Sjögren's endpoint
Adrian Kessler · Sep 23, 2026